[The results of 2 and 1/2 years of work of the Russian Multicenter Trial on the Treatment of Acute Myeloid Leukemias in Adults]

Ter Arkh. 1995;67(7):8-12.
[Article in Russian]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Disease-Free Survival
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / mortality
  • Male
  • Mercaptopurine / administration & dosage
  • Remission Induction
  • Russia / epidemiology
  • Survival Analysis
  • Time Factors

Substances

  • Cytarabine
  • Etoposide
  • Cyclophosphamide
  • Mercaptopurine
  • Daunorubicin

Supplementary concepts

  • 7+3 protocol